Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.

作者: Christoph Springfeld , Christiane Wiecha , Romy Kunzmann , Ulrike Heger , Wilko Weichert

DOI: 10.1245/S10434-015-4617-X

关键词:

摘要: Background Perioperative chemotherapy improves survival in patients with advanced esophagogastric cancer, but the optimal treatment regimen remains unclear. More intensive may improve outcome, also increase toxicity and complications.

参考文章(38)
Sylvie Lorenzen, Susanne Blank, Florian Lordick, Jörg-Rüdiger Siewert, Katja Ott, Prediction of Response and Prognosis by a Score Including Only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients Annals of Surgical Oncology. ,vol. 19, pp. 2119- 2127 ,(2012) , 10.1245/S10434-012-2254-1
Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho, Susanne Unverzagt, Chemotherapy for advanced gastric cancer Cochrane Database of Systematic Reviews. ,vol. 8, pp. 0- 0 ,(2017) , 10.1002/14651858.CD004064.PUB4
R C Fields, V E Strong, M Gönen, K A Goodman, N P Rizk, D P Kelsen, D H Ilson, L H Tang, M F Brennan, D G Coit, M A Shah, Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. British Journal of Cancer. ,vol. 104, pp. 1840- 1847 ,(2011) , 10.1038/BJC.2011.175
U. Fink, C. Schuhmacher, H. J. Stein, R. Busch, H. Feussner, H. J. Dittler, A. Helmberger, K. Böttcher, J. R. Siewert, Preoperative chemotherapy for stage III–IV gastric carcinoma: Feasibility, response and outcome after complete resection British Journal of Surgery. ,vol. 82, pp. 1248- 1252 ,(2005) , 10.1002/BJS.1800820930
Ulrich Ronellenfitsch, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E. Slanger, Bryan Burmeister, David Kelsen, Donna Niedzwiecki, Christoph Schuhmacher, Susan Urba, Cornelis van de Velde, Thomas N. Walsh, Marc Ychou, Katrin Jensen, Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data European Journal of Cancer. ,vol. 49, pp. 3149- 3158 ,(2013) , 10.1016/J.EJCA.2013.05.029
Andrew M. Lowy, Paul F. Mansfield, Steven D. Leach, Richard Pazdur, Pamela Dumas, Jaffer A. Ajani, Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Annals of Surgery. ,vol. 229, pp. 303- 308 ,(1999) , 10.1097/00000658-199903000-00001
Nils Homann, Claudia Pauligk, Kim Luley, Thomas Werner Kraus, Hans-Peter Bruch, Akin Atmaca, Frank Noack, Hans-Michael Altmannsberger, Elke Jäger, Salah-Eddin Al-Batran, Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel International Journal of Cancer. ,vol. 130, pp. 1706- 1713 ,(2012) , 10.1002/IJC.26180
Franz G. Bader, Florian Lordick, Ulrich Fink, Karen Becker, Heinz Höfler, Raymonde Busch, Jörg R. Siewert, Katja Ott, Paclitaxel in the neoadjuvant treatment for adeno carcinoma of the distal esophagus (AEG I). A comparison of two phase II trials with long-term follow-up. Onkologie. ,vol. 31, pp. 366- 372 ,(2008) , 10.1159/000135515
Katja Ott, Susanne Blank, Karen Becker, Rupert Langer, Wilko Weichert, Wilfried Roth, Leila Sisic, Annika Stange, Dirk Jäger, Markus Büchler, Jörg-Rüdiger Siewert, Florian Lordick, Factors predicting prognosis and recurrence in patients with esophago-gastric adenocarcinoma and histopathological response with less than 10 % residual tumor Langenbeck's Archives of Surgery. ,vol. 398, pp. 239- 249 ,(2013) , 10.1007/S00423-012-1039-0
HH Hartgrink, EPM Jansen, NCT van Grieken, CJH van de Velde, Gastric cancer – Authors' reply The Lancet. ,vol. 374, pp. 1594- 1595 ,(2009) , 10.1016/S0140-6736(09)61948-6